Miss Lovegrove, who is a MRC Clinical Research Training Fellow at NDS, was awarded the prize for her research on SLC34A1-associated hypercalcaemia and hypophosphatemia in kidney stone disease. The study indicates that renal phosphate leak may be a common cause of kidney stone disease and that genetic testing would identify individuals with kidney stone disease who would benefit from oral phosphate replacement.
Speaking of her success, Miss Lovegrove commented: 'Presenting our work was an excellent opportunity to demonstrate the potential translation of genetic research in kidney stone disease to clinical care for patients. It was exciting to be awarded the prize, and for the endourological community to engage with the results we hope to take forwards as the basis for a clinical trial.'